C Mariette

Summary

Affiliation: CHRU de Lille
Country: France

Publications

  1. ncbi Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez CHRU, Place de Verdun, 59037 Lille Cedex, France
    World J Surg 29:39-45. 2005
  2. ncbi [Mesenteric panniculitis]
    G Piessen
    , , CHU, Place de Verdun 59037, Lille Cedex, France
    Ann Chir 131:85-90. 2006
  3. ncbi [Is there still a role for surgery in esophageal carcinoma in 2007?]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, Place de Verdun, CHRU, 59037 Lille Cedex
    Bull Cancer 94:63-9. 2007
  4. ncbi The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire, Lille, France
    Ann Surg 247:365-71. 2008
  5. ncbi [What's new in esophageal cancer treatment]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, CHRU, Lille
    Presse Med 36:496-500. 2007
  6. ncbi [A case of stomach cancer]
    C Mariette
    , Lille
    J Chir (Paris) 142:184-6. 2005
  7. ncbi Is there a place for esogastric cancer surgery in cirrhotic patients?
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez Centre Hospitalier Régional Universitaire and University of Lille II, Place de Verdun, 59037, Lille Cedex, France
    Ann Surg Oncol 15:680-2. 2008
  8. ncbi [Apprenticeship in laparoscopic surgery: Tools and methods for the surgeon in training]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHU Lille
    J Chir (Paris) 143:221-5. 2006
  9. ncbi [Perioperative care in digestive surgery. Guidelines for the French society of digestive surgery (SFCD)]
    C Mariette
    , , CHRU de Lille, Place de Verdun, 59037 Lille, France
    Ann Chir 130:108-24. 2005
  10. ncbi Oesophagogastric junction adenocarcinoma: which therapeutic approach?
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France
    Lancet Oncol 12:296-305. 2011

Collaborators

Detail Information

Publications74

  1. ncbi Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez CHRU, Place de Verdun, 59037 Lille Cedex, France
    World J Surg 29:39-45. 2005
    ..In conclusion, the clinical, histologic, and oncologic differences between SCC and ADC justify a differentiated therapeutic concept for these two tumor entities and distinct consideration in clinical reports...
  2. ncbi [Mesenteric panniculitis]
    G Piessen
    , , CHU, Place de Verdun 59037, Lille Cedex, France
    Ann Chir 131:85-90. 2006
    ..Mesenteric panniculitis usually has an uneventful clinical course and resolves spontaneously in a variable delay...
  3. ncbi [Is there still a role for surgery in esophageal carcinoma in 2007?]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, Place de Verdun, CHRU, 59037 Lille Cedex
    Bull Cancer 94:63-9. 2007
    ....
  4. ncbi The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire, Lille, France
    Ann Surg 247:365-71. 2008
    ....
  5. ncbi [What's new in esophageal cancer treatment]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, CHRU, Lille
    Presse Med 36:496-500. 2007
    ..For patients whose tumor is inoperable, a combination of radiation and chemotherapy is the standard treatment...
  6. ncbi [A case of stomach cancer]
    C Mariette
    , Lille
    J Chir (Paris) 142:184-6. 2005
  7. ncbi Is there a place for esogastric cancer surgery in cirrhotic patients?
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez Centre Hospitalier Régional Universitaire and University of Lille II, Place de Verdun, 59037, Lille Cedex, France
    Ann Surg Oncol 15:680-2. 2008
  8. ncbi [Apprenticeship in laparoscopic surgery: Tools and methods for the surgeon in training]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHU Lille
    J Chir (Paris) 143:221-5. 2006
    ..This new technology should enable a better preparation of young surgeons for the operating room of the future...
  9. ncbi [Perioperative care in digestive surgery. Guidelines for the French society of digestive surgery (SFCD)]
    C Mariette
    , , CHRU de Lille, Place de Verdun, 59037 Lille, France
    Ann Chir 130:108-24. 2005
  10. ncbi Oesophagogastric junction adenocarcinoma: which therapeutic approach?
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France
    Lancet Oncol 12:296-305. 2011
    ..Through a team approach, members from all diagnostic and therapeutic disciplines, such as gastroenterologists, surgeons, oncologists, radiologists, and radiotherapists, can effectively administer a range of treatment modalities...
  11. ncbi [Esophagectomy by triple approach: primary thoracotomy, laparotomy, and cervicotomy - The MacKeown Procedure]
    C Mariette
    , CHRU - Lille
    J Chir (Paris) 143:373-7. 2006
  12. ncbi Surgery alone in the curative treatment of localised oesophageal carcinoma
    C Mariette
    Service de chirurgie digestive et générale Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Eur J Surg Oncol 30:869-76. 2004
    ..To document the results of surgery alone in patients with localised oesophageal carcinoma...
  13. ncbi Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Lille, France
    Ann Thorac Surg 78:1177-83. 2004
    ..To identify factors affecting postoperative course and survival after esophagectomy for cancer and reasons for improved survival over time...
  14. ncbi [Radiotherapy and chemotherapy in the treatment of oesophageal carcinoma]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 129:489-96. 2004
    ..Surgery appears more and more as an adjuvant therapy in the curative treatment of oesophageal cancer, especially for advanced tumours...
  15. ncbi Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase
    Christophe Mariette
    Inserm Unit 837, and Department of Digestive and Oncological Surgery, University Hospital Claude Huriez, Lille Cedex, France
    Surgery 143:58-71. 2008
    ....
  16. ncbi [Surgical management of post-operative peritonitis]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHU, Lille
    J Chir (Paris) 143:84-7. 2006
    ..Imaging exams such as CT will aid in diagnosis and guide the therapeutic approach. Treatment specifically adapted to the etiologic cause must be thorough and complete from the start...
  17. ncbi [Diverticula of the middle third of the oesophagus: resection via right thoracotomy]
    C Mariette
    , , Lille
    J Chir (Paris) 142:378-80. 2005
  18. ncbi [Complications following oesophagectomy: mechanism, detection, treatment and prevention]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU, Lille
    J Chir (Paris) 142:348-54. 2005
    ..Anastomotic leak, conduit necrosis, and pulmonary failure are the most serious complications. The management of complications following oesophagectomy is reviewed in the following section...
  19. ncbi The safety of the same-day discharge for selected patients after laparoscopic fundoplication: a prospective cohort study
    Christophe Mariette
    Department of Digestive and General Surgery, C Huriez Hospital University Hospital Center, Place de Verdun 59037, Lille Cedex, France
    Am J Surg 194:279-82. 2007
    ..We conducted a prospective cohort study to assess the acceptability, feasibility and safety of day-case laparoscopic fundoplication for gastroesophageal reflux disease in an university-based tertiary care center...
  20. ncbi Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma
    C Mariette
    Department of Digestive and General Surgery, University Hospital Claude Huriez, Centre Hospitalier Regional Universitaire, France
    Br J Surg 93:1077-83. 2006
    ..The aim of this study was to determine the effect of neoadjuvant radiochemotherapy (RCT) on postoperative complications and survival after surgery for locally advanced oesophageal squamous cell carcinoma...
  21. ncbi [Perioperative care in digestive surgery]
    C Mariette
    , Hopital C. Huriez, CHRU, Lille
    J Chir (Paris) 142:14-28. 2005
  22. ncbi [Lymphadenectomy in surgery for cancers of the stomach and esophagus]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 145:12S21-12S29. 2008
    ..Articles from the surgical literature with the highest levels of evidence are analyzed. Practical guidelines for treatment choice are proposed...
  23. ncbi Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France University of Lille II, Lille, France
    Lancet Oncol 8:545-53. 2007
    ..Moreover, surgery should be kept in mind as salvage treatment in patients with no morphological response or persistent tumour after definitive chemoradiotherapy...
  24. ncbi [Practical considerations in prescribing immunonutrition]
    C Mariette
    Service de chirurgie digestive et générale Hôpital C Huriez, CHRU Lille
    J Chir (Paris) 145:9S10-4. 2008
    ..In a question-and-answer format, we discuss the practical aspects of prescribing immunonutrition to provide assistance in this area and thus optimize the application of the guidelines and patient management...
  25. ncbi [Laparoscopic fundoplication: current data]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 142:278-83. 2005
    ..Long-term follow-up is required to evaluate dysphagia and quality-of-life...
  26. ncbi Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    C Gronnier
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 149:e23-33. 2012
    ..A multidisciplinary approach is essential for optimal diagnosis and management...
  27. ncbi [Treatment of thoracic anastomotic leaks after oesophagectomy with self-expanding and extractible covered stent]
    A Brams
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU de Lille, Place de Verdun, 59037 Lille Cedex, France
    Gastroenterol Clin Biol 32:41-5. 2008
    ..Intrathoracic, covered oesophageal stents appears to reduce leak-morbidity after oesophagectomy and may be considered as a cost-effective treatment alternative...
  28. ncbi Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases
    J P Triboulet
    Service de Chirurgie Digestive et Generale, Clinique Chirurgicale Adultes Est, Chru Lille Hopital Huriez, Place de Verdun, 59037 Lille Cedex, France
    Arch Surg 136:1164-70. 2001
    ....
  29. ncbi Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction
    C Mariette
    , CHRU de Lille Place de Verdun, 59037 cedex, Lille, France
    Eur J Surg Oncol 29:588-93. 2003
    ..In adenocarcinomas of the OGJ that can be treated curatively, a transection with a 8 cm oesophagectomy above the tumour in fresh specimen should be performed, and by thoracoabdominal approach for tumours type I and II...
  30. ncbi [Patients surviving 5 years after curative oesophagectomy for oesophageal cancer]
    C Mariette
    , , CHRU, Place de Verdun, 59037 Lille, France
    Ann Chir 128:536-42. 2003
    ..016). CONCLUSION: Complete surgical resection allows 5-year survival. Factors predictive of long-term survival assessed in preoperative evaluation, dysphagia and tumour stage, should be useful to select patients for neoadjuvant treatment...
  31. ncbi [Reconstruction after total circular pharyngolaryngectomy: comparison between gastric interposition and free jejunal flap]
    C Mariette
    , , CHRU place de Verdun, 59037 Lille, France
    Ann Chir 127:431-8. 2002
    ..CONCLUSION: Surgical ablation is a viable option for advanced hypopharyngeal and cervical oesophageal neoplasms, and stomach interposition is the preferred method of reconstruction...
  32. ncbi Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?
    Guillaume Piessen
    Department of Digestive and Oncological Surgery, University Hospital Claude Huriez Centre Hospitalier Régional Universitaire, Lille, France
    Ann Surg Oncol 14:2036-44. 2007
    ..Salvage surgery may have a survival benefit otherwise complete. Our aim was to identify predictors of R0 resection in these patients...
  33. ncbi Surgical management of and long-term survival after adenocarcinoma of the cardia
    C Mariette
    , , Place de Verdun, 59037 Lille Cedex, France
    Br J Surg 89:1156-63. 2002
    ..Further prospective studies are needed to confirm the equivalence between transthoracic and transabdominal approaches...
  34. ncbi Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma
    C Mariette
    , , , Lille, France
    Br J Surg 90:1367-72. 2003
    ..These results support the proposal that EUS should be performed in all patients with oesophageal cancer, not only for staging patients before therapy but also to determine prognosis...
  35. ncbi [Preoperative prognostic factors for squamous cell carcinomas of the thoracic esophagus]
    C Mariette
    , , CHRU, Lille
    Gastroenterol Clin Biol 25:468-72. 2001
    ..009). CONCLUSION: Our study confirms that dysphagia and nodal involvement on the CT-scan are simple preoperative prognostic factors in patients with resectable squamous cell carcinoma of the thoracic esophagus...
  36. ncbi Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway
    Christophe Mariette
    , Place de Verdun, 59045 Lille Cedex, France
    Biochem J 377:701-8. 2004
    ..This new mechanism of regulation of MUC4 mucin gene points out an important role for bile acids as key molecules in targeting MUC4 overexpression in early stages of oesophageal carcinogenesis...
  37. ncbi Factors predictive of complete resection of operable esophageal cancer: a prospective study
    Christophe Mariette
    , Lille, France
    Ann Thorac Surg 75:1720-6. 2003
    ..Deviation axis on the barium swallow and morphologic response to neoadjuvant radiochemotherapy are variables available for all patients at onset of therapeutic management...
  38. ncbi FOLFIRI chemotherapy in patients with advanced non resectable esophageal or junctional adenocarcinoma: a pilot study
    C Ferte
    Department of Medical Oncology, University Hospital, Lille, France
    J Chemother 23:358-61. 2011
    ..To conclude, FOLFIRI regimen appears quite active, with an acceptable safety profile in patients with advanced esophageal or junctional adenocarcinoma...
  39. ncbi Peptic ulcer of the gastric tube after esophagectomy for cancer: clinical implications
    G Piessen
    Department of Digestive and General Surgery, University Hospital Claude Huriez, Lille, Cedex, France
    Dis Esophagus 20:542-5. 2007
    ..Long-term treatment with an anti-secretory proton pump inhibitor may decrease esophageal complications of duodeno-gastric-esophageal reflux and could prevent the recurrence of gastric tube ulcers...
  40. ncbi Acute respiratory disease syndrome with preoperative chronomodulated chemoradiotherapy in patients with esophageal cancer. Early termination of a phase I trial
    A Adenis
    Department of Gastrointestinal and Urological Oncology, Centre Oscar Lambret, Lille, France
    Eur J Surg Oncol 34:30-5. 2008
    ..Without definitively ruling out any possible impact of chronomodulation in that setting, our data reinforce the need of a better selection of patients aimed to be treated by CRT plus surgery...
  41. ncbi Surgery after induction chemoradiotherapy for oesophageal cancer
    P Guillem
    Department of Digestive and General Surgery, University Hospital, 59037, Lille, France
    Eur J Surg Oncol 29:158-65. 2003
    ..We need to improve postchemoradiotherapy restaging to be sure that chemoradiotherapy will provide the same long-term survival rates as surgery...
  42. ncbi [Cervical and upper-third thoracic oesophageal carcinoma: a single pathological entity?]
    G Piessen
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHU Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 130:86-91. 2005
    ..Cervical and upper-third thoracic oesophageal carcinomas are considered as a single pathological entity. The aim of this study was to compare postoperative and oncological results after surgical resection in these two locations...
  43. ncbi [Oesophageal cancer in patients with head and neck cancers: therapeutic implications]
    C Mariette
    , , CHRU, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 127:757-64. 2002
    ....
  44. ncbi Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications
    N Briez
    Departments of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire de Lille, France
    Br J Surg 99:1547-53. 2012
    ..The aim of this study was to test the hypothesis that hybrid minimally invasive oesophagectomy (HMIO) decreases the 30-day MPPC rate without compromising oncological outcomes...
  45. ncbi Outcome of day-case laparoscopic fundoplication for gastro-esophageal reflux disease
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 148:50-3. 2011
    ..To assess the acceptability, feasibility and results of day-case laparoscopic fundoplication for gastro-esophageal reflux disease (GERD) in an university tertiary care center...
  46. ncbi Adenocarcinoma in a gastric tube after esophagectomy for esophageal carcinoma
    A Lamblin
    , CHRU, Lille, France
    Dis Esophagus 16:158-9. 2003
    ..We report three cases of patients who had this clinical presentation. We suggest an approach to postoperative management of ESCC to identify early tumors in gastric tubes and to allow endoscopic or surgical curative treatment...
  47. ncbi [Oesophageal squamous cell carcinoma stade III. State of surgery after radiochemotherapy (RCT)]
    J P Triboulet
    Service de Chirurgie Digestive et Generale, Rez de Jardin Aile Ouest, Hopital Claude Huriez, Place de Verdun, 59037 Lille Cedex, France
    Cancer Radiother 10:456-61. 2006
    ..Surgery may be proposed for selected non-responders patients and some complete pathology response in expert center...
  48. ncbi Oesophageal cancer: how radical should surgery be?
    C Mariette
    Department of Digestive and Oncological Surgery, Centre Hospitalier Regional Universitaire, University Hospital C Huriez, Place de Verdun, 59037 Lille Cedex, France
    Eur J Surg Oncol 38:210-3. 2012
    ..Oesophagectomy for carcinoma can be viewed as comprising two components: resection of the oesophagus and resection of the enveloping lymphatics. Controversy exists regarding how extensive these two components should be...
  49. ncbi Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma
    G Piessen
    INSERM, U837, Team 5 Mucins, epithelial differentiation and carcinogenesis Centre de Recherche Jean Pierre Aubert, Place de Verdun, Lille Cedex, France
    J Clin Pathol 62:1144-6. 2009
    ....
  50. ncbi Reconstruction after gastrectomy: which technique is best?
    G Piessen
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU de Lille, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 147:e273-83. 2010
    ..In the long-term, quality of life seems better mainly in patients with small-resected tumors associated with a good prognosis...
  51. ncbi Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha
    Guillaume Piessen
    Unité INSERM 560, Place de Verdun, 59045 Lille Cedex, France
    Biochem J 402:81-91. 2007
    ..These results bring new insights into MUC4 up-regulation in oesophageal carcinoma associated with bile reflux...
  52. ncbi Photodynamic therapy for early oesophageal cancer
    V Maunoury
    Gastroenterology Department, University Hospital, Lille, France
    Dig Liver Dis 37:491-5. 2005
    ..Photodynamic therapy is an endoscopic treatment of early cancers based on the photosensitisation of neoplasms following the administration of a photosensitiser prior to laser light-induced tissue destruction...
  53. ncbi [Interest in agents for adhesion prevention after gynecologic surgery]
    S Ait Menguellet
    clinique de gynécologie, Hopital Jeanne de Flandre, Centre Hospitalier Régional Universitaire CHRU de Lille, 2, Avenue Oscar Lambret, 59037 Lille Cedex, France
    Gynecol Obstet Fertil 35:290-6. 2007
    ..As far as other barrier agents are concerned, data are still insufficient to recommend them for clinical use. There is a need for other randomised controlled trials in order to evaluate functional efficiency of anti adhesion agents...
  54. ncbi Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation
    Guillaume Piessen
    Department of Digestive and Oncological Surgery, University Hospital Claude Huriez, Lille, France
    Ann Surg 250:878-87. 2009
    ..To test the hypothesis that signet ring cell (SRC) histology has a negative prognostic value in patients with gastric adenocarcinoma (ADC)...
  55. ncbi [Oesophageal cancer: what's new during the last 10 years?]
    Jean Pierre Triboulet
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, rue Polonovski, 59037 Lille Cedex
    Bull Cancer 95:425-31. 2008
    ..Therapeutic strategies have markedly changed for 10 years, and their respective place is specified for each histological types and according to tumour location...
  56. ncbi Relationships between mucinous gastric carcinoma, MUC2 expression and survival
    Emmanuelle Leteurtre
    INSERM U560, Lille, France
    World J Gastroenterol 12:3324-31. 2006
    ....
  57. ncbi [Gastric diverticulum]
    F Bouras
    , , Lille, France
    J Chir (Paris) 144:145. 2007
  58. ncbi [Diaphragmatic hernia after esophagectomy: 2 case reports and review of the literature]
    A Franceschi
    , , CHRU, 59037 Lille, France
    Ann Chir 127:62-4. 2002
    ..The aim of this study was to report two cases of transhiatal herniation following esophagectomy, to analyse the contributing factors of this complication and to expose the preventive treatment, by means of a review of the literature...
  59. ncbi [Total gastrectomy for cancer with Roux-en-Y esophago-jejunostomy reconstruction]
    N Briez
    , , CHRU - Lille
    J Chir (Paris) 145:147-52. 2008
  60. ncbi [Factors predictive of complete resection of operable esophageal cancer: review of 746 patients]
    Christophe Mariette
    , , CHRU, 59037 Lille Cedex, France
    Gastroenterol Clin Biol 26:454-62. 2002
    ..04).CONCLUSION: Complete resection of esophageal cancer is predictable. After validation with an independent population the findings presented here could be used to establish stratification criteria for future therapeutic trials...
  61. ncbi Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease
    Christophe Mariette
    , CHRU, Lille, France
    Cancer 97:1616-23. 2003
    ....
  62. ncbi [In Process Citation]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 145:12S21-9. 2008
    ..Articles from the surgical literature with the highest levels of evidence are analyzed. Practical guidelines for treatment choice are proposed...
  63. ncbi [In Process Citation]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 145:12S21-9. 2008
    ..Articles from the surgical literature with the highest levels of evidence are analyzed. Practical guidelines for treatment choice are proposed...
  64. ncbi [Type I neurofibromatosis, pheochromocytoma and somatostatinoma of the ampulla. Literature review]
    R Caiazzo
    , , CHRU, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 131:393-7. 2006
    ..This pathological association appears non hasardous and surgical ampullectomy offers a good alternative to pancreaticoduodenectomy in localised tumors treatment...
  65. ncbi [Urothelial tumor and colonic cancer in the context of a syndrome of hereditary predisposition to HNPCC colonic cancer]
    A de la Taille
    Service de Chirurgie Viscerale, Hopital Claude Huriez, Lille, France
    Prog Urol 10:1204-7. 2000
    ....
  66. ncbi A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis
    Nicolas Jonckheere
    Unité INSERM 560, Place de Verdun, 59045 Lille Cedex, France
    Oncogene 23:5729-38. 2004
    ....
  67. ncbi Should resectable esophageal cancer be resected?
    Christophe Mariette
    Ann Surg Oncol 13:447-9. 2006
  68. ncbi Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102
    Laurent Bedenne
    University Hospital Le Bocage, Dijon, France
    J Clin Oncol 25:1160-8. 2007
    ..Therefore, a randomized trial was carried out to compare, in responders only, chemoradiation alone with chemoradiation followed by surgery in patients with locally advanced tumors...
  69. ncbi Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors
    Alain Sauvanet
    Department of Digestive Surgery, , Clichy
    J Am Coll Surg 201:253-62. 2005
    ..015), age more than 60 years (p < 0.001), anastomotic leakage (p < 0.001), and abdominal complications (p = 0.003). CONCLUSIONS: ASA score is a reliable predictive factor of operative mortality and morbidity after resection of AGEJ...
  70. ncbi The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products
    Eric Boulanger
    Laboratoire de Biologie Vasculaire et Cellulaire, INTS, 6 Rue A Cabanel, 75739 Paris cedex 15, France
    Nephrol Dial Transplant 19:2208-16. 2004
    ....
  71. ncbi [Primary adenocarcinoma of the cervical esophagus arising from heterotopic gastric mucosa]
    Jean-Michel Balon
    Gastroenterol Clin Biol 27:836-8. 2003
  72. ncbi The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
    Lionel Apetoh
    Institut Gustave Roussy IGR, Villejuif, France
    Immunol Rev 220:47-59. 2007
    ..This knowledge may be clinically exploited to predict the immunogenicity and hence the efficacy of chemotherapeutic regimens...
  73. ncbi [Hepatic actinomycosis associated with gastric leiomyosarcoma. A case report]
    Thérèse Delebecq
    Gastroenterol Clin Biol 26:102-3. 2002
  74. ncbi [Extensive ganglioneuromatosis of the esophagus: uncommon location of Von Recklinghausen's disease]
    Vincent Maunoury
    Gastroenterol Clin Biol 29:1181-2. 2005